Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smarter program help more people avoid diabetes?

NCT ID NCT07412912

First seen Mar 06, 2026 · Last updated Jun 19, 2026 · Updated 18 times

Summary

This study tests whether an enhanced version of the Intensive Diabetes Prevention Program (IDPP) works better than the standard program at recruiting and keeping participants in district health centres. Researchers will compare the two approaches in 170 adults with prediabetes, looking at factors like attendance, satisfaction, and cost. The goal is to find practical ways to improve real-world delivery of diabetes prevention.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Intensive Diabetes Prevention Program (behavioural intervention)

What this could lead to

If successful, this could show how to better implement diabetes prevention programs in community health centres, helping more people with prediabetes avoid developing diabetes.

What could go wrong

This is an early implementation study with only 170 participants, so results may not apply to other settings. The focus is on recruitment and retention, not directly on health outcomes.

Conditions

The condition(s) this trial relates to.

prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.